Most linked-to pages

Jump to navigation Jump to search

Showing below up to 50 results in range #11,601 to #11,650.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Niedzwiecki D, et al. J. Clin. Oncol. (2011) cited as Ref 563 in DOI: 10.1038/s41392-020-0110-5 (Q9826)‏‎ (2 links)
  2. Luke Logan kickoff for 65 yds for a touchback (9-30-17)‏‎ (2 links)
  3. Yang X, et al. Vitr. Cell Dev. Biol. Anim. (2013) cited as Ref 506 in DOI: 10.1038/s41392-020-0110-5 (Q9769)‏‎ (2 links)
  4. JK Scott kickoff for 65 yds for a touchback (10-14-17a)‏‎ (2 links)
  5. Shek CC, et al, Pediatrics (2003), cited as Ref 26 in DOI: 10.1016/j.jcv.2020.104372 (Q10473)‏‎ (2 links)
  6. Greten FR, et al. Cell (2004) cited as Ref 282 in DOI: 10.1038/s41392-020-0110-5 (Q9545)‏‎ (2 links)
  7. Chan JF-W, et al, Lancet (2020) cited as Ref 9 in DOI: 10.3201/eid2605.200146 (Q11215)‏‎ (2 links)
  8. Gazdar AF, et al. Nat. Rev. Cancer (2017) cited as Ref 571 in DOI: 10.1038/s41392-020-0110-5 (Q9834)‏‎ (2 links)
  9. JK Scott kickoff for 65 yds for a touchback (9-30-17e)‏‎ (2 links)
  10. Li L, et al. Ochsner J. (2013) cited as Ref 514 in DOI: 10.1038/s41392-020-0110-5 (Q9777)‏‎ (2 links)
  11. Rasmussen SA, et al, Am. J. Obstet. Gynecol. (2020), cited as Ref 34 in DOI: 10.1016/j.jcv.2020.104372 (Q10481)‏‎ (2 links)
  12. Gonzalez-Torres C, et al. Arch. Med. Res. (2017) cited as Ref 290 in DOI: 10.1038/s41392-020-0110-5 (Q9553)‏‎ (2 links)
  13. Schott AF, et al. Clin. Cancer Res. (2013) cited as Ref 579 in DOI: 10.1038/s41392-020-0110-5 (Q9842)‏‎ (2 links)
  14. Kawikova I, et al. Brain Res. (2015) cited as Ref 522 in DOI: 10.1038/s41392-020-0110-5 (Q9785)‏‎ (2 links)
  15. Wang X, et al, Clin. Infect. Dis. (2020), cited as Ref 42 in DOI: 10.1016/j.jcv.2020.104372 (Q10489)‏‎ (2 links)
  16. Karanikas V, et al. J. Transl. Med. (2008) cited as Ref 298 in DOI: 10.1038/s41392-020-0110-5 (Q9561)‏‎ (2 links)
  17. End of 2nd Quarter (10-7-17) (Q2696)‏‎ (2 links)
  18. Diaz-Padilla I, et al. Gynecol. Oncol. (2015) cited as Ref 587 in DOI: 10.1038/s41392-020-0110-5 (Q9850)‏‎ (2 links)
  19. Mrizak D, et al. J. Natl Cancer Inst. (2015) cited as Ref 530 in DOI: 10.1038/s41392-020-0110-5 (Q9793)‏‎ (2 links)
  20. Marinelli KA, et al, J. Hum. Lact. (2020), cited as Ref 50 in DOI: 10.1016/j.jcv.2020.104372 (Q10497)‏‎ (2 links)
  21. Ihle JN, et al. Trends Genet. (1995) cited as Ref 306 in DOI: 10.1038/s41392-020-0110-5 (Q9569)‏‎ (2 links)
  22. JK Scott kickoff for 62 yds Reginald Todd return for 22 yds to the MisSt 40 (11/11/17) (Q3643)‏‎ (2 links)
  23. Smith DC, et al. Clin. Cancer Res. (2014) cited as Ref 595 in DOI: 10.1038/s41392-020-0110-5 (Q9858)‏‎ (2 links)
  24. American Horse (Q6249)‏‎ (2 links)
  25. Bronisz A, et al. Cancer Res. (2014) cited as Ref 538 in DOI: 10.1038/s41392-020-0110-5 (Q9801)‏‎ (2 links)
  26. Chan JF, et al, J. Clin. Microbiol. (2020), cited as Ref 58 in DOI: 10.1016/j.jcv.2020.104372 (Q10505)‏‎ (2 links)
  27. Kralovics R, et al. N. Engl. J. Med. (2005) cited as Ref 314 in DOI: 10.1038/s41392-020-0110-5 (Q9577)‏‎ (2 links)
  28. You can expect to change that back to that same question if it could be damned I might when I kept things I could be a way to. [IndianCountry/Changing] (Q6142)‏‎ (2 links)
  29. Zito PM, et al. () cited as Ref 603 in DOI: 10.1038/s41392-020-0110-5 (Q9866)‏‎ (2 links)
  30. Pitt JM, et al. J. Clin. Invest. (2016) cited as Ref 546 in DOI: 10.1038/s41392-020-0110-5 (Q9809)‏‎ (2 links)
  31. Jiang C, et al. J. Exp. Clin. Cancer Res. (2017) cited as Ref 322 in DOI: 10.1038/s41392-020-0110-5 (Q9585)‏‎ (2 links)
  32. Pan S, et al. ACS Med. Chem. Lett. (2010) cited as Ref 611 in DOI: 10.1038/s41392-020-0110-5 (Q9874)‏‎ (2 links)
  33. Colnot DR, et al. Cancer Immunol. Immunother. (2003) cited as Ref 554 in DOI: 10.1038/s41392-020-0110-5 (Q9817)‏‎ (2 links)
  34. Dong E, et al, Lancet Infect Dis (2020), cited as Ref 3 in DOI:10.14218/ERHM.2020.00023 (Q10778)‏‎ (2 links)
  35. Kim SY, et al. Cell. Signal. (2013) cited as Ref 330 in DOI: 10.1038/s41392-020-0110-5 (Q9593)‏‎ (2 links)
  36. Kraggerud SM, et al. Endocr. Rev. (2013) cited as Ref 619 in DOI: 10.1038/s41392-020-0110-5 (Q9882)‏‎ (2 links)
  37. Wilson N, et al, Euro Surveill (2009), cited as Ref 11 in DOI:10.14218/ERHM.2020.00023 (Q10786)‏‎ (2 links)
  38. Yang Y, et al. Mol. Cancer (2017) cited as Ref 338 in DOI: 10.1038/s41392-020-0110-5 (Q9601)‏‎ (2 links)
  39. JK Scott kickoff for 49 yds Christian Kirk return for 20 yds to the TexAM 36 (10-7-17)‏‎ (2 links)
  40. Huang C, et al, Lancet (2020), cited as Ref 1 in DOI: 10.1007/s11886-020-01293-2 (Q10995)‏‎ (2 links)
  41. Konopleva M, et al. Cancer Discov. (2016) cited as Ref 627 in DOI: 10.1038/s41392-020-0110-5 (Q9890)‏‎ (2 links)
  42. Forget that he is and have a home in other words you don't think there can be any compromise between keeping the Navajo way of life and having the prosperity of a white man. [IndianCountry/Past] (Q5938)‏‎ (2 links)
  43. Xia W, et al. Oncotarget (2017) cited as Ref 346 in DOI: 10.1038/s41392-020-0110-5 (Q9609)‏‎ (2 links)
  44. Zhou P, et al, Nature (2020), cited as Ref 9 in DOI: 10.1007/s11886-020-01293-2 (Q11003)‏‎ (2 links)
  45. Sakamuri D, et al. Mol. Cancer Ther. (2018) cited as Ref 635 in DOI: 10.1038/s41392-020-0110-5 (Q9898)‏‎ (2 links)
  46. Kahn M, et al. Nat. Rev. Drug Discov. (2014) cited as Ref 122 in DOI: 10.1038/s41392-020-0110-5 (Q9385)‏‎ (2 links)
  47. Luke Logan kickoff for 65 yds Henry Ruggs III return for 22 yds to the Alab 22 (9-30-17) (Q2502)‏‎ (2 links)
  48. Wang Q, et al. Br. J. Cancer (2017) cited as Ref 354 in DOI: 10.1038/s41392-020-0110-5 (Q9617)‏‎ (2 links)
  49. JK Scott kickoff for 62 yds Chandler Curtis return for 40 yds to the Mercr 43 (11/18/17) (Q3714)‏‎ (2 links)
  50. The Human Protein Atlas , et al, (Accessed April 1, 2020), cited as Ref 17 in DOI: 10.1007/s11886-020-01293-2 (Q11011)‏‎ (2 links)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:MostLinkedPages"